Position in ABBV
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$3,345,553
+$402,696 QoQ
Shares Held
13,295
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#1,572
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CENTAURUS FINANCIAL, INC. holds $28,490,833 across 13 Drug Manufacturers - General names. ABBV ranks #2 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,081 | $14,490,315 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
13,295 | $3,345,553 | |
| 3 | JNJ |
Johnson & Johnson
|
12,384 | $3,145,164 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,912 | $1,530,692 | |
| 5 | AMGN |
Amgen Inc
|
3,413 | $1,235,915 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,694 | $972,059 | |
| 7 | NVS |
Novartis AG
|
5,748 | $900,826 | |
| 8 | PFE |
Pfizer Inc
|
36,772 | $885,469 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,345,553 | 13,295 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $2,942,857 | 13,531 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $3,097,181 | 13,555 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,083,649 | 13,318 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $1,577,213 | 8,497 | Shares | Sole | 2025-08-29 | |
| 2025-03-31 | $1,808,367 | 8,631 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,511,693 | 8,507 | Shares | Sole | 2025-03-12 | |
| 2024-09-30 | $1,642,836 | 8,319 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,221,222 | 7,120 | Shares | Sole | 2024-09-23 | |
| 2024-03-31 | $1,335,703 | 7,335 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,183,350 | 7,636 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $1,266,860 | 8,499 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,091,313 | 8,100 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,311,502 | 14,504 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $2,191,916 | 13,563 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,937,858 | 14,439 | Shares | Sole | 2022-12-05 | |
| 2022-06-30 | $2,109,319 | 13,772 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $2,857,026 | 17,624 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,395,496 | 17,692 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,673,926 | 15,518 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,734,656 | 15,400 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,333,053 | 12,318 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $916,025 | 8,549 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $810,995 | 9,259 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,023,919 | 10,429 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $626,891 | 8,228 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||